Affordable Access

deepdyve-link
Publisher Website

Identification of capillary rarefaction using intracoronary wave intensity analysis with resultant prognostic implications for cardiac allograft patients.

Authors
  • Broyd, Christopher J1, 2
  • Hernández-Pérez, Francisco3
  • Segovia, Javier3
  • Echavarría-Pinto, Mauro1
  • Quirós-Carretero, Alicia1
  • Salas, Clara3
  • Gonzalo, Nieves1
  • Jiménez-Quevedo, Pilar1
  • Nombela-Franco, Luis1
  • Salinas, Pablo1
  • Núñez-Gil, Ivan1
  • Del Trigo, Maria1
  • Goicolea, Javier3
  • Alonso-Pulpón, Luis3
  • Fernández-Ortiz, Antonio1
  • Parker, Kim2
  • Hughes, Alun4
  • Mayet, Jamil2
  • Davies, Justin2
  • Escaned, Javier1
  • 1 Department of Cardiology, Hospital Clinico San Carlos IDISSC and Universidad Complutense de Madrid, Prof Martin Lagos, 28040 Madrid, Spain. , (Spain)
  • 2 National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.
  • 3 Department of Cardiology, Hospital Puerto de Hierro-Majadahonda, Calle Manuel de Falla, 1, 28222 Majadahonda, Madrid, Spain. , (Spain)
  • 4 Population Science & Experimental Medicine, Institute of Cardiovascular Science, University College London, 62 Huntley St, Fitzrovia, London, WC1E 6DD, UK.
Type
Published Article
Journal
European Heart Journal
Publisher
Oxford University Press
Publication Date
May 21, 2018
Volume
39
Issue
20
Pages
1807–1814
Identifiers
DOI: 10.1093/eurheartj/ehx732
PMID: 29253131
Source
Medline
Language
English
License
Unknown

Abstract

Techniques for identifying specific microcirculatory structural changes are desirable. As such, capillary rarefaction constitutes one of the earliest changes of cardiac allograft vasculopathy (CAV) in cardiac allograft recipients, but its identification with coronary flow reserve (CFR) or intracoronary resistance measurements is hampered because of non-selective interrogation of the capillary bed. We therefore investigated the potential of wave intensity analysis (WIA) to assess capillary rarefaction and thereby predict CAV. Fifty-two allograft patients with unobstructed coronary arteries and normal left ventricular (LV) function were assessed. Adequate aortic pressure and left anterior descending artery flow measurements at rest and with intracoronary adenosine were obtained in 46 of which 2 were lost to follow-up. In a subgroup of 15 patients, simultaneous RV biopsies were obtained and analysed for capillary density. Patients were followed up with 1-3 yearly screening angiography. A significant relationship with capillary density was noted with CFR (r = 0.52, P = 0.048) and the backward decompression wave (BDW) (r = -0.65, P < 0.01). Over a mean follow-up of 9.3 ± 5.2 years patients with a smaller BDW had an increased risk of developing angiographic CAV (hazard ratio 2.89, 95% CI 1.12-7.39; P = 0.03). Additionally, the index BDW was lower in those who went on to have a clinical CAV-events (P = 0.04) as well as more severe disease (P = 0.01). Within cardiac transplant patients, WIA is able to quantify the earliest histological changes of CAV and can predict clinical and angiographic outcomes. This proof-of-concept for WIA also lends weight to its use in the assessment of other disease processes in which capillary rarefaction is involved.

Report this publication

Statistics

Seen <100 times